Morgan Stanley's reiteration of an Overweight rating and maintaining a $70 price target on Endava (NYSE:DAVA) is a positive signal for the stock. This shows that the analyst continues to have confidence in the company's growth prospects and potential upside. As a result, this news is likely to have a positive short-term impact on Endava's stock price.